Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
Research is scarce on exercise and periods, review finds
There is no shortage of advice for women on what to eat, how to train or what supplements to take during their menstrual cycles, but . . .
Viral success: McMaster researchers discover new way to protect against infections like COVID-19
An exciting therapeutic discovery involving synthetic aptamers being worked on by McMaster researchers is showing promise in protecting against viral infections like COVID-19. Researchers Matthew . . .
Project breathes new life into care for patients with interstitial lung disease
Tim Brady received life-altering news in 2017 that he has interstitial lung disease (ILD). What he didn’t receive at the time of diagnosis was appropriate . . .
Discover how Our Research is making an Impact
